Abedin, Laga .
HRN: 26-16-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2024
11/07/2024
IV
4.5g
Q8hr
Sepsis Prob Secondary To Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes